ClinConnect ClinConnect Logo
Search / Trial NCT02978638

Electrical Stimulation for Continence After Spinal Cord Injury

Launched by PALO ALTO VETERANS INSTITUTE FOR RESEARCH · Nov 30, 2016

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Spinal Cord Injury Bladder Capacity Electrical Stimulation Continence Urodynamics

ClinConnect Summary

This clinical trial is studying a device called the Finetech Vocare Bladder System, which uses electrical stimulation to help improve bladder control for people who have had a spinal cord injury. The goal is to help patients achieve better continence (the ability to control urination) and to make it easier for them to empty their bladders. Unlike some previous treatments that involved cutting nerves, this study focuses on using the device to stimulate the nerves without surgery, potentially leading to better outcomes and fewer side effects.

To be eligible for this study, participants must have a complete spinal cord injury (meaning they have no feeling or movement below the injury) for at least two years and experience problems with bladder emptying and control. Those interested should be aware that they will need to follow specific guidelines, and they will undergo assessments to ensure they qualify. Participants can expect to receive care and support throughout the trial, and their experiences may help improve treatments for others with similar conditions in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects will be included if they meet all of the following criteria:
  • Complete spinal cord injury (AIS grade A) of at least 2 years duration with neurological level (ISNCSCI level) below C4
  • Impaired bladder emptying due to Detrusor External Sphincter Dyssynergia-DESD (unco-ordinated contraction of bladder and external urethral sphincter) as shown on video-urodynamic testing.
  • Impaired continence due to detrusor hyper-reflexia
  • Exclusion Criteria:
  • Subjects will be excluded if they meet any of the following criteria:
  • Absence of reflex contractions of the bladder as shown on urodynamic testing
  • Absence of reflex contractions of the external urethral sphincter as shown on urodynamic testing with EMG
  • External sphincterotomy, urethral stricture or previous urethral or sphincter or bladder or prostate surgery
  • History of pelvic fracture
  • Subjects on anticoagulants or with coagulation disorders
  • Immunosuppressed subjects
  • Active or recurrent pressure ulcers, particularly in sacral, ischial or trochanteric areas
  • Active untreated infection
  • Active implanted medical device such as cardiac pacemaker or defibrillator
  • Progressive spinal cord injury
  • Pregnancy
  • Mechanical ventilator dependency
  • Any other significant co-morbidity or illness that would preclude their participation or increase the risk to them of participating in the study
  • Inability or unwillingness to follow study protocol or give informed consent

About Palo Alto Veterans Institute For Research

The Palo Alto Veterans Institute for Research (PAVIR) is a nonprofit organization dedicated to advancing medical research and improving healthcare outcomes for veterans. Located in Palo Alto, California, PAVIR collaborates with the Department of Veterans Affairs and leading academic institutions to conduct innovative clinical trials and research initiatives. The institute focuses on a wide range of health issues, including mental health, chronic diseases, and rehabilitation, aiming to translate findings into effective treatments and interventions. Committed to enhancing the quality of life for veterans, PAVIR fosters a multidisciplinary approach, leveraging cutting-edge technology and expertise to address the unique health challenges faced by this population.

Locations

Cleveland, Ohio, United States

Albuquerque, New Mexico, United States

San Jose, California, United States

Palo Alto, California, United States

Patients applied

0 patients applied

Trial Officials

Graham H. Creasey, MD

Principal Investigator

Palo Alto Veterans Institute for Research

Reza Ehsanian, MD PhD

Study Director

University of New Mexico

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials